|
期刊封面: |
期刊名称:CANCER 研究方向:ONCOLOGY 医学-肿瘤学 |
| ISSN: | 0008-543X |
| E-ISSN: | 1097-0142 |
| Impact Factor: | 6.102 |
| 5-Year Impact Factor: | |
| 自引率: | 2.90% |
| h-index: | 277 |
| CiteScore: | 10.5 |
| JCR分区: | Q1 |
| 中科院分区: | 2区 |
| 出版周期: | Semimonthly |
| 是否OA: | No |
| 出版年份: | 暂无数据 |
| 出版地区: | UNITED STATES |
| 期刊官方网址: | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0142 |
| 期刊投稿地址: | https://mc.manuscriptcentral.com/cancer |
| SCI期刊coverage: |
Science Citation Index Science Citation Index Expanded |
| PubMed Central (PMC)链接: | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0008-543X%5BISSN%5D |
| 审稿周期: | 3-4个月 |
| 投稿命中率: | 80%左右 |
| 期刊简介: | Cancers (ISSN 2072-6694; CODEN: CANCCT) is an open access journal of oncology published monthly online by MDPI. Cancers (ISSN 2072-6694) is an international, peer-reviewed open access journal on oncology. It publishes reviews, regular research papers and short communications. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, unique features of this journal: manuscripts regarding research proposals and research ideas will be particularly welcomed electronic files or software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material we also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds we accept studies showing meaningful but negative results. While there are many journals that focus on cancer studies, none of them actively accepts negative results. As a result, most negative data end up not being in the public domain even if the data were meaningfully negative and the study well designed. By accepting those negative results, our journal encourages scientists to share those data so that they would not need to repeat the experiments that somebody else has already done. Open Access - free for readers, with publishing fees paid by authors or their institutions. Rapid publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 29 days after submission; acceptance to publication is undertaken in 6 days (median values for papers published in this journal in 2016). For Cancers (ISSN 2072-6694), authors are asked to pay a fee of 850 CHF (Swiss Francs) per processed paper, but only if the article is accepted for publication in this journal after peer-review and possible revision of the manuscript. Note that many national and private research funding organizations and universities explicitly cover such fees for articles originated in funded research projects. Discounts are available for authors from institutes that participate with MDPI''s membership program. In addition to Swiss Francs (CHF), we also accept payment of the fees in Euros (EUR), US Dollars (USD) or Chinese Yuan (CNY). Current exchange rates published at XE plus 5% exchange commission apply. |
| 稿件要求: |
1、SCI稿件控制10页以上,4600单词字数以上(未翻译中文字数8600字数以上);文章撰写语言为英语;(单栏格式,单倍行距,内容10号字体,文章内容包含:题目,所有作者姓名,作者单位,通信作者邮箱,摘要,关键词,内容,总结,项目基金,参考文献,所有作者相片+简介) 2、未一稿多投,未在其他期刊上公开发表;拒绝抄袭、机械性的稿件; 3、稿件重复率控制10%以内,论文务必保证原创性、图标、公式、引文等要素齐备,已发表或引用过度的文章将不会被出版和检索; 4、稿件必须有较好的英语表达水平,有图,有表,有公式,有数据或设计,有算法(方案,模型),实验,仿真等; 5、参考文献控制25条以上,参考文献引用一半以上控制在近5年以内;图表分辨率必须达到300dpi;参考文献与文献综述能反映国际研究前沿; 6、国家自然科学基金、科技部或教育部课题资助的论文优先; 7、论文语言需要经过国外专家翻译、润色(自行安排或由IASRS提供此项服务); 8、投稿初稿不需要排版,审稿通过后提供期刊模版、修改意见和建议。 |
| 联系方式: |
投稿邮箱:submit@iasrs.cn(投稿邮件内容:文章领域或方向+姓名+电话+微信号+QQ号) 微信客服:"SCIEI_service" 联系电话(微信同号):(+86) 19898831008 联系人:廖编辑
|
期刊发表:SCI核心期刊发表,发表学术论文网站,国际论文发表,论文怎么发表,国外期刊投稿,国际论文期刊,SCI期刊推荐,国际期刊推荐,论文如何发表,发表学术论文,怎样发表学术论文,SCI论文官网,SCI论文翻译,SCI论文润色,SCI论文查重系统,期刊查询,SCI期刊源列表